donepezil has been researched along with risperidone in 40 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (5.00) | 18.2507 |
2000's | 20 (50.00) | 29.6817 |
2010's | 16 (40.00) | 24.3611 |
2020's | 2 (5.00) | 2.80 |
Authors | Studies |
---|---|
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
Sen, S; Sinha, N | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Brown, AM; Bruening-Wright, A; Kramer, J; Kuryshev, YA; Myatt, G; Obejero-Paz, CA; Verducci, JS | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Ancill, RJ; Geizer, M | 1 |
Burke, WJ; Keller, BK; Magnuson, TM | 1 |
Baik, J; Han, IW; Koo, MS; Kwak, YT | 1 |
Ehmann, TS; Khanbhai, I; MacEwan, GW; Wrixon, C | 1 |
Adler, DN; Brenner, G; Davis, KL; Friedman, JI; Harvey, PD; Howanitz, E; Parrella, M; Temporini, H; White, L | 1 |
Bar, F; Baruch, Y; Rabey, JM; Strous, RD; Stryjer, R | 1 |
Cherry, D; Cummings, JL; Frank, JC; Hewett, L; Kemp, B; Kohatsu, ND; Mittman, B | 1 |
Lin, SK; Liu, HC; Sung, SM | 1 |
Jia, X; Parier, JL; Pesco-Koplowitz, L; Xie, C; Zhao, Q | 1 |
Hori, K; Inada, T; Oda, T; Tominaga, I | 1 |
Freeman, MP; Gelenberg, AJ; Gnanadesikan, M | 1 |
Cullen, EI; Khan, A; Kumar, D; Perdomo, CA; Pratt, RD; Preskorn, SH; Reyes, JF | 1 |
Arya, P; Butler, R; Warner, J | 1 |
Duaso, E; Formiga, F; Fort, I; Pérez-Castejón, JM; Riu, S; Ruiz, D | 1 |
DeVane, CL; Horner, MD; Markowitz, JS; McGurk, SR; Nahas, Z; Palecko, S; Risch, SC | 1 |
Barzó, P; Janka, Z; Kálmán, J; Sas, K; Szakács, R | 1 |
Ago, Y; Baba, A; Hashimoto, H; Kawasaki, T; Koda, K; Matsuda, T | 1 |
Bogetto, F; Marino, F; Montemagni, C; Perrone, D; Rocca, P | 1 |
Athey, R; Forlano, R; Singh, D | 1 |
Borg, C; Convers, P; Desmales, S; Laurent, B; Thomas Antérion, C | 1 |
Abbasi, SH; Akhondzadeh, S; Gerami, M; Ghoreishi, A; Karamghadiri, N; Noroozian, M; Rezazadeh, SA | 1 |
Karamihalev, S; Prickaerts, J; van Goethem, NP | 1 |
Boettger, S; Jellestad, L; Jenewein, J; Stocker, L | 1 |
Huang, LQ; Li, P; Li, YP; Liu, Y; Pan, X; Yang, Y; Yin, Y; Zhao, ZQ; Zhao, ZX; Zhuang, J | 1 |
Grayson, B; Harte, MK; Marsh, S; McLean, SL; Neill, JC; Zarroug, SH | 1 |
Allouche, A; Almari, B; Fischer, N; Grayson, B; Harte, MK; Jackson, J; Koziel, V; McLean, SL; Neill, JC; Pillot, T; Watremez, W | 1 |
Agrawal, M; Alexander, A; Antimisiaris, SG; Chougule, MB; Saraf, S; Shoyele, SA | 1 |
Buckley, N; Le Couteur, DG; Litchfield, M; McLachlan, AJ; Narayan, SW; Pearson, SA; Zoega, H | 1 |
Chen, KL; Chen, SD; Dong, Q; Dou, KX; Huang, YY; Shen, XN; Tan, L; Teng, T; Wang, J; Wang, RZ; Yu, JT; Zhang, RQ; Zhao, QH; Zhong, XL; Zhou, XY | 1 |
Cox, GR; Haslam, R; Ure, A; Williams, K | 1 |
7 review(s) available for donepezil and risperidone
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Guidelines for managing Alzheimer's disease: Part II. Treatment.
Topics: Advance Directives; Alzheimer Disease; Carbamates; Cholinesterase Inhibitors; Disease Progression; Donepezil; Humans; Indans; Lorazepam; Patient Education as Topic; Phenylcarbamates; Piperidines; Risperidone; Rivastigmine | 2002 |
Alternatives to lithium and divalproex in the maintenance treatment of bipolar disorder.
Topics: Acetates; Amines; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Calcium Channel Blockers; Carbamazepine; Clozapine; Cyclohexanecarboxylic Acids; Dibenzothiazepines; Donepezil; Fatty Acids, Omega-3; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Indans; Lamotrigine; Lithium Carbonate; Olanzapine; Piperazines; Piperidines; Pirenzepine; Quetiapine Fumarate; Risperidone; Thiazoles; Topiramate; Treatment Outcome; Triazines; Valproic Acid | 2003 |
Dementia.
Topics: Alzheimer Disease; Antipsychotic Agents; Benzodiazepines; Cognition; Dementia; Donepezil; Galantamine; Ginkgo biloba; Haloperidol; Humans; Indans; Memantine; Olanzapine; Phenylcarbamates; Physostigmine; Phytotherapy; Piperidines; Risperidone; Rivastigmine; Selegiline; Tacrine; Vitamin E | 2004 |
Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs.
Topics: Administration, Intranasal; Alzheimer Disease; Animals; Biological Availability; Blood-Brain Barrier; Brain; Deferoxamine; Donepezil; Drug Carriers; Drug Liberation; Galantamine; Humans; Mucociliary Clearance; Nanoparticles; Nasal Mucosa; Nose; Olfactory Bulb; Risperidone; Tissue Distribution | 2018 |
Pharmacological treatments for psychotic symptoms in dementia: A systematic review with pairwise and network meta-analysis.
Topics: Aripiprazole; Dementia; Donepezil; Humans; Memantine; Network Meta-Analysis; Risperidone; United States | 2022 |
Acetylcholinesterase inhibitors for autistic spectrum disorders.
Topics: Acetylcholine; Adolescent; Autism Spectrum Disorder; Child; Child, Preschool; Cholinesterase Inhibitors; Donepezil; Galantamine; Humans; Risperidone; Rivastigmine | 2023 |
6 trial(s) available for donepezil and risperidone
Article | Year |
---|---|
A double blind placebo controlled trial of donepezil adjunctive treatment to risperidone for the cognitive impairment of schizophrenia.
Topics: Adult; Aged; Antipsychotic Agents; Cognition Disorders; Donepezil; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Indans; Male; Middle Aged; Neuropsychological Tests; Piperidines; Risperidone; Schizophrenia; Schizophrenic Psychology | 2002 |
Pharmacokinetic and safety assessments of concurrent administration of risperidone and donepezil.
Topics: Adult; Area Under Curve; Biological Availability; Cross-Over Studies; Donepezil; Drug Interactions; Humans; Indans; Male; Piperidines; Risperidone | 2003 |
Concurrent administration of donepezil HCl and risperidone in patients with schizophrenia: assessment of pharmacokinetic changes and safety following multiple oral doses.
Topics: Administration, Oral; Adult; Aged; Antipsychotic Agents; Area Under Curve; Cholinesterase Inhibitors; Donepezil; Drug Combinations; Drug Interactions; Humans; Indans; Male; Middle Aged; Piperidines; Risperidone; Schizophrenia | 2004 |
Double-blind donepezil-placebo crossover augmentation study of atypical antipsychotics in chronic, stable schizophrenia: a pilot study.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Cholinesterase Inhibitors; Clozapine; Cross-Over Studies; Donepezil; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Indans; Male; Middle Aged; Nootropic Agents; Olanzapine; Piperidines; Psychiatric Status Rating Scales; Psychotic Disorders; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2007 |
A 12-week, double-blind, placebo-controlled trial of donepezil adjunctive treatment to risperidone in chronic and stable schizophrenia.
Topics: Adult; Antipsychotic Agents; Chronic Disease; Donepezil; Double-Blind Method; Female; Humans; Indans; Male; Mental Status Schedule; Neuropsychological Tests; Nootropic Agents; Piperidines; Prospective Studies; Risperidone; Schizophrenia; Treatment Outcome; Young Adult | 2008 |
Low-Dose Atypical Antipsychotic Risperidone Improves the 5-Year Outcome in Alzheimer's Disease Patients with Sleep Disturbances.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antipsychotic Agents; Caregivers; Donepezil; Female; Humans; Hypnotics and Sedatives; Indans; Male; Melatonin; Neuropsychological Tests; Nootropic Agents; Nursing Homes; Piperidines; Polysomnography; Pyridines; Risperidone; Sleep Wake Disorders; Treatment Outcome; Zolpidem | 2015 |
27 other study(ies) available for donepezil and risperidone
Article | Year |
---|---|
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model.
Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
MICE models: superior to the HERG model in predicting Torsade de Pointes.
Topics: ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Models, Theoretical; Patch-Clamp Techniques; Predictive Value of Tests; Torsades de Pointes | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Combination of risperidone and donepezil in Lewy body dementia.
Topics: Aged; Antipsychotic Agents; Cholinesterase Inhibitors; Dementia; Donepezil; Drug Therapy, Combination; Humans; Indans; Male; Parkinson Disease; Piperidines; Risperidone | 1998 |
Extrapyramidal side effects in a patient treated with risperidone plus donepezil.
Topics: Aged; Alzheimer Disease; Antipsychotic Agents; Basal Ganglia Diseases; Cholinesterase Inhibitors; Cognition Disorders; Donepezil; Drug Therapy, Combination; Female; Humans; Indans; Piperidines; Risperidone | 1998 |
Relation between cholinesterase inhibitor and Pisa syndrome.
Topics: Aged; Alzheimer Disease; Carbamates; Cholinesterase Inhibitors; Donepezil; Dopamine Antagonists; Dystonia; Female; Humans; Indans; Memory Disorders; Middle Aged; Neuroprotective Agents; Nootropic Agents; Phenylcarbamates; Piperidines; Posture; Psychomotor Agitation; Risperidone; Rivastigmine; Syndrome | 2000 |
Donepezil in schizophrenia--is it helpful? An experimental design case study.
Topics: Adult; Antipsychotic Agents; Cholinesterase Inhibitors; Cognition; Donepezil; Drug Therapy, Combination; Humans; Indans; Male; Piperidines; Risperidone; Schizophrenia; Treatment Outcome | 2001 |
Donepezil management of schizophrenia with associated dementia.
Topics: Aged; Antiparkinson Agents; Antipsychotic Agents; Comorbidity; Dementia; Donepezil; Drug Therapy, Combination; Female; Humans; Indans; Mental Status Schedule; Middle Aged; Nootropic Agents; Parkinson Disease; Piperidines; Psychiatric Status Rating Scales; Risperidone; Schizophrenia | 2002 |
Extrapyramidal side-effect due to drug combination of risperidone and donepezil.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antipsychotic Agents; Basal Ganglia Diseases; Donepezil; Drug Interactions; Drug Therapy, Combination; Female; Humans; Indans; Nootropic Agents; Piperidines; Risperidone | 2002 |
'Awakenings' in demented patients.
Topics: Aged; Alzheimer Disease; Antipsychotic Agents; Awareness; Cholinesterase Inhibitors; Delusions; Depressive Disorder; Donepezil; Female; Humans; Indans; Piperidines; Risperidone; Schizophrenia; Schizophrenic Psychology; Sick Role | 2003 |
[Risperidone and cerebrovascular adverse effects in elderly patients with dementia].
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Cerebrovascular Disorders; Cholinesterase Inhibitors; Dementia, Vascular; Donepezil; Female; Galantamine; Humans; Indans; Male; Piperidines; Risperidone | 2006 |
[Amnesic syndrome following lesion of the fornix or does reversible Korsakow's syndrome exist?].
Topics: Amnesia, Anterograde; Citalopram; Donepezil; Female; Fornix, Brain; Humans; Indans; Intracranial Aneurysm; Korsakoff Syndrome; Middle Aged; Neurosurgical Procedures; Nootropic Agents; Piperidines; Risperidone; Rupture, Spontaneous; Subarachnoid Hemorrhage; Vasospasm, Intracranial | 2007 |
Galantamine and donepezil differently affect isolation rearing-induced deficits of prepulse inhibition in mice.
Topics: Aconitine; Acoustic Stimulation; alpha7 Nicotinic Acetylcholine Receptor; Analysis of Variance; Animals; Animals, Outbred Strains; Apomorphine; Behavior, Animal; Cholinesterase Inhibitors; Dizocilpine Maleate; Donepezil; Dose-Response Relationship, Drug; Galantamine; Indans; Male; Mecamylamine; Mice; Neural Inhibition; Nicotinic Antagonists; Piperidines; Receptors, Nicotinic; Reflex, Startle; Risperidone; Social Isolation | 2008 |
Risperidone, olanzapine and quetiapine in the treatment of behavioral and psychological symptoms in patients with Alzheimer's disease: preliminary findings from a naturalistic, retrospective study.
Topics: Activities of Daily Living; Aged; Alzheimer Disease; Antipsychotic Agents; Behavior; Benzodiazepines; Cognition; Data Interpretation, Statistical; Dibenzothiazepines; Donepezil; Endpoint Determination; Female; Galantamine; Humans; Indans; Long-Term Care; Male; Neuropsychological Tests; Nootropic Agents; Olanzapine; Phenylcarbamates; Piperidines; Psychiatric Status Rating Scales; Quetiapine Fumarate; Retrospective Studies; Risperidone; Rivastigmine; Treatment Outcome | 2007 |
Neuroleptic malignant syndrome and catatonia in a patient with dementia.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Catatonia; Chlorpromazine; Cholinesterase Inhibitors; Cognition Disorders; Creatine Kinase; Dementia; Disease Progression; Donepezil; Female; Humans; Indans; Lorazepam; Muscle Rigidity; Neuroleptic Malignant Syndrome; Olanzapine; Piperidines; Recurrence; Risperidone | 2008 |
An odd manifestation of the Capgras syndrome: loss of familiarity even with the sexual partner.
Topics: Aged; Amnesia; Antipsychotic Agents; Atrophy; Brain; Capgras Syndrome; Donepezil; Hallucinations; Humans; Indans; Male; Memory; Movement Disorders; Neuropsychological Tests; Nootropic Agents; Parkinsonian Disorders; Piperidines; Recognition, Psychology; Risperidone; Sexual Behavior; Spouses; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2008 |
Drug-induced sialorrhoea and excessive saliva accumulation.
Topics: Antipsychotic Agents; Benzodiazepines; Cholinesterase Inhibitors; Clozapine; Deglutition Disorders; Donepezil; Galantamine; Humans; Hypnotics and Sedatives; Indans; Phenylcarbamates; Pilocarpine; Piperidines; Quality of Life; Risperidone; Rivastigmine; Sialorrhea | 2009 |
Donepezil and the alpha-7 agonist PHA 568487, but not risperidone, ameliorate spatial memory deficits in a subchronic MK-801 mouse model of cognitive impairment in schizophrenia.
Topics: Acetylcholinesterase; alpha7 Nicotinic Acetylcholine Receptor; Animals; Antipsychotic Agents; Aza Compounds; Cholinesterase Inhibitors; Cognition Disorders; Dioxins; Disease Models, Animal; Dizocilpine Maleate; Donepezil; Indans; Male; Mice, Inbred C57BL; Nicotinic Agonists; Nootropic Agents; Piperidines; Risperidone; Schizophrenia; Schizophrenic Psychology; Spatial Memory | 2014 |
Challenges in the management of delirium: a case of augmentation with donepezil following inadequate response and adverse effects with risperidone.
Topics: Anticholinergic Syndrome; Antiparkinson Agents; Antipsychotic Agents; Biperiden; Burns; Cholinesterase Inhibitors; Delirium; Diagnosis, Differential; Donepezil; Drug Administration Routes; Drug Synergism; Humans; Indans; Male; Middle Aged; Muscle Rigidity; Physostigmine; Piperidines; Risperidone; Treatment Outcome | 2015 |
Nicotinic α7 and α4β2 agonists enhance the formation and retrieval of recognition memory: Potential mechanisms for cognitive performance enhancement in neurological and psychiatric disorders.
Topics: Analysis of Variance; Animals; Antipsychotic Agents; Benzamides; Bridged Bicyclo Compounds; Cholinesterase Inhibitors; Donepezil; Dose-Response Relationship, Drug; Exploratory Behavior; Female; Indans; Locomotion; Mental Recall; Nicotine; Nicotinic Agonists; Piperidines; Rats; Recognition, Psychology; Retention, Psychology; Risperidone | 2016 |
Stabilized Low-n Amyloid-β Oligomers Induce Robust Novel Object Recognition Deficits Associated with Inflammatory, Synaptic, and GABAergic Dysfunction in the Rat.
Topics: Amyloid beta-Peptides; Animals; Brain; Cognition; Disease Models, Animal; Donepezil; Female; gamma-Aminobutyric Acid; Inflammation; Male; Memory Disorders; Neurons; Nootropic Agents; Peptide Fragments; Random Allocation; Rats; Recognition, Psychology; Risperidone; Rolipram; Synapses | 2018 |
Anticholinergic medicines use among older adults before and after initiating dementia medicines.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Australia; Cholinergic Antagonists; Cholinesterase Inhibitors; Dementia; Deprescriptions; Donepezil; Drug Prescriptions; Female; Humans; Male; Memantine; Middle Aged; Retrospective Studies; Risperidone; Rivastigmine | 2019 |